Report cover image

Vaccine Logistics

Published Jul 01, 2025
Length 269 Pages
SKU # GJOB20209315

Description

Global Vaccine Logistics Market to Reach US$3.8 Billion by 2030

The global market for Vaccine Logistics estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Warehousing Service segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$826.7 Million While China is Forecast to Grow at 7.3% CAGR

The Vaccine Logistics market in the U.S. is estimated at US$826.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$778.9 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Vaccine Logistics Market - Key Trends & Drivers Summarized

What Makes Vaccine Logistics Uniquely Complex Compared to Other Cold Chain Markets?
Vaccine logistics occupies a distinct niche within the cold chain logistics industry, demanding ultra-reliable temperature control, time-sensitive distribution, and regulatory-compliant traceability across geographies. Unlike general pharmaceuticals or perishables, vaccines are biologics with narrow thermal thresholds-often between 2°C and 8°C-and in some cases (like mRNA vaccines) requiring deep-frozen transport at -70°C. These conditions must be maintained continuously through first-mile manufacturing, mid-mile air/sea transport, and last-mile delivery to clinics or immunization centers. Even minor temperature excursions can render vaccines unusable, resulting in health risks, regulatory non-compliance, and financial losses.

COVID-19 vaccine deployment revealed the scale and complexity of vaccine logistics, driving investments in ultra-low temperature freezers, IoT-enabled thermal packaging, and visibility software. Beyond pandemics, routine immunization programs managed by governments, UNICEF, and Gavi require annual delivery of billions of doses to remote and underserved locations. This necessitates specialized packaging (phase-change materials, vacuum insulation panels), passive cooling boxes, and multi-modal coordination. Challenges also include managing reverse logistics for unused or expired doses, ensuring customs clearance efficiency, and coordinating between national immunization programs and global health agencies.

Which Technologies Are Reshaping the Future of Vaccine Transport and Storage?
Vaccine logistics is being transformed by digital supply chain platforms, real-time condition monitoring, and AI-assisted route planning. Connected sensor technologies embedded in vaccine packaging or transport containers monitor temperature, humidity, vibration, and light exposure in real time. These sensors transmit data via Bluetooth or cellular networks to cloud-based dashboards, enabling proactive risk mitigation. Pharmaceutical logistics providers now use AI algorithms to predict bottlenecks, optimize delivery windows, and reroute shipments based on weather or geopolitical disruptions.

Another innovation is the use of drone logistics and electric vehicles (EVs) for last-mile delivery in remote or urban-congested areas. Solar-powered cold boxes and portable vaccine refrigerators are also being deployed in off-grid regions. Data analytics is improving forecasting and inventory planning, reducing both stockouts and vaccine wastage. Blockchain pilots are being explored for tamper-proof tracking of vaccine provenance, batch records, and regulatory audit trails. These digital layers are essential to building trust, especially in international vaccine trade, where regulatory harmonization is often lacking.

Where Is the Demand for Specialized Vaccine Logistics Growing Most Rapidly?
Demand for specialized vaccine logistics is surging across both developed and emerging markets, driven by expanded immunization schedules, adult vaccine uptake, and epidemic preparedness initiatives. In high-income countries, the focus is on building resilient cold chains for seasonal influenza, RSV, shingles, and COVID-19 boosters. These regions are also investing in smart warehousing, temperature-controlled distribution hubs, and API integrations between vaccine manufacturers, distributors, and public health systems.

In low- and middle-income countries (LMICs), the emphasis is on last-mile access, cold chain electrification, and strengthening of public-private logistics partnerships. Global health initiatives-such as COVAX, Gavi’s Cold Chain Equipment Optimization Platform (CCEOP), and PATH’s NextGen cold chain solutions-are driving deployment of solar refrigerators, digital VVMs (vaccine vial monitors), and training for health workers. Countries in Sub-Saharan Africa, Southeast Asia, and Latin America are also adopting national vaccine logistics management systems (vLMIS) to track doses, manage inventories, and plan replenishments. Additionally, domestic vaccine manufacturing growth in India, China, and Brazil is increasing the need for intra-national cold chain capacity and compliance systems.

What Forces Are Powering the Global Vaccine Logistics Market Forward?
The growth in the vaccine logistics market is driven by several factors, including expanded global immunization programs, rising demand for temperature-sensitive biologics, and increasing public and private investment in cold chain infrastructure. COVID-19 created a paradigm shift, exposing vulnerabilities in global vaccine distribution and catalyzing efforts to build more resilient, agile, and traceable logistics systems. National governments are now incorporating cold chain logistics planning into pandemic preparedness strategies and public health budgets, ensuring long-term demand stability.

Pharmaceutical innovation is another driver. With the growth of mRNA platforms, vector-based vaccines, and novel adjuvanted formulations, the temperature and handling requirements of vaccines are becoming more complex. This is stimulating demand for advanced packaging, passive cooling systems, and active reefer technologies across land, air, and sea modes. Moreover, international regulatory tightening-from WHO prequalification to national Good Distribution Practices (GDP)-is pushing logistics providers to enhance quality assurance, documentation, and risk management practices.

Private equity and venture capital investment in pharmaceutical logistics startups, along with global logistics majors expanding cold chain capacity (e.g., DHL, UPS, Kuehne+Nagel), further reflect growing market interest. As climate change, global health threats, and demand for equitable vaccine access reshape the global health landscape, the vaccine logistics market will remain central to delivering immunization outcomes at scale-across urban centers, rural outposts, and everything in between.

SCOPE OF STUDY:

The report analyzes the Vaccine Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service (Transportation Service, Warehousing Service, Value-Added Services); End-User (Hospitals End-User, Drug Manufacturers & Distributors End-User, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -
  • 3PL—Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebrüder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx (DHL subsidiary)
  • Nippon Express
AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

269 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Vaccine Logistics – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Global Vaccination Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure
Expansion of Cold Chain Networks Spurs Growth in Temperature-Controlled Storage and Transportation Solutions
Rising Demand for Last-Mile Delivery Efficiency Expands Addressable Market for Specialized Vaccine Distribution Services
Innovation in Temperature Monitoring and IoT Integration Strengthens the Business Case for Smart Vaccine Logistics
Increasing Use of mRNA and Biologic Vaccines Drives Adoption of Ultra-Cold Chain Logistics Technologies
Emerging Markets Push for Immunization Equity Fuels Investment in Rural and Remote Area Distribution Capabilities
Integration with National Immunization Programs Enhances Demand Forecasting and Inventory Management Systems
Growth in Outsourcing by Pharma Companies Supports Expansion of Specialized Vaccine Logistics Providers
Standardization of Packaging, Labeling, and Handling Protocols Improves Cross-Border Vaccine Movement
Real-Time Visibility and Exception Management Tools Improve Cold Chain Integrity and Risk Mitigation
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Vaccine Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Warehousing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Value-Added Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for Drug Manufacturers & Distributors End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 25: USA 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 28: USA 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 31: Canada 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 34: Canada 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
JAPAN
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 37: Japan 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 40: Japan 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
CHINA
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 43: China 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 46: China 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
EUROPE
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 49: Europe 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 52: Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 55: Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
FRANCE
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 58: France 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 61: France 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
GERMANY
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 64: Germany 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 67: Germany 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 70: Italy 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 73: Italy 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
UNITED KINGDOM
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 76: UK 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 79: UK 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 82: Spain 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 85: Spain 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 88: Russia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 91: Russia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
AUSTRALIA
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 109: Australia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 112: Australia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
INDIA
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: India Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 115: India 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: India Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 118: India 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
LATIN AMERICA
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
MIDDLE EAST
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 175: Iran 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 178: Iran 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 181: Israel 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 184: Israel 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 193: UAE 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 196: UAE 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
AFRICA
Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 205: Africa 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 208: Africa 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
IV. COMPETITION
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.